CNS Hemangioblastoma
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Treatment of Von Hippel-Lindau (VHL)-Related Hemangioblastoma With PTK787/ZK 222584 (NCT00052013) | Novartis Pharmaceuticals | 2003-02-01 |
Track CNS Hemangioblastoma automatically
Every clearance here is in the API, with alerts when new ones post.